Objective: To study the 6MWT and NT-proBNP contribution to the prognosis evaluation of patients with NYHA class II-III heart failure in the Yalgado Ouédraogo Teaching Hospital.
Methods: We carried out a nine months prospective observational cohort from the 1 February to the 31 October 2020. Patients with NYHA class II-III HF who consented to participate were included in the study.